AGX816

SARS-CoV-2 Spike (RBD, aa 331-524) Recombinant Antigen

suitable for ELISA, suitable for immunodiffusion

• 別名: 2019-nCoV, COVID-19
• UNSPSCコード: 51201600
• NACRES: NA.26

特性

• リコンビナント: expressed in HEK 293 cells
• 品質水準: 100
• 形状: liquid
• 保管条件: avoid repeated freeze/thaw cycles
• テクニック: ELISA: suitable; immunodiffusion: suitable; lateral flow assay: suitable
• 輸送温度: dry ice

詳細

詳細

COVID-19 Spike (RBD, aa 331-524) Recombinant Antigen, expressed in HEK293 cells, Cat. No. AGX816 is for use in ELISA, and Lateral Flow Assay as Positive Control.

ターゲットの説明

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 nucleoprotein antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).

物理的形状

Purified protein in 10mM Phosphate Buffered Saline without preservatives, pH 7.0.

再構成

Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

保管および安定性

Stable for 1 year at -10°C to -25°C from date of receipt. Avoid repeated freeze/thaw cycles.

免責事項

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

安全性情報

• 保管分類コード: 12 - Non Combustible Liquids
• WGK: WGK 2
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable